Fact CheckerSign in

NCT04560621Completed

Managed Problem Solving for ART Adherence and HIV Care Retention Delivered by Community Health Workers

Managed Problem Solving for ART Adherence and HIV Care Retention Delivered by Community Health Workers: A Stepped Wedge Hybrid Type II Effectiveness Implementation Trial

Source: ClinicalTrials.gov · Last updated 3 Jul 2025

Brief summary (registry, in English)

The Managed Problem Solving (MAPS) behavioral intervention is an EBP for behavior change in people living with HIV (PLWH). The investigators propose that MAPS can be delivered by trained Community Health Workers (CHWs). The use of CHWs to deliver MAPS is justified by their ability to develop trusting relationships with their clients and the need for task shifting in busy clinics. In order to also address retention in care, the investigators will adapt MAPS to also focus on problem solving activities tailored toward retention in care (now termed MAPS+). CHWs will be located in clinics to implement MAPS+ to improve viral suppression and care retention in PLWH. Data-to-care allows for identification of people who are lost to care and link these patients back to care. Currently, medication adherence and retention in HIV care are not targeted in data-to-care so the investigators will build on this approach to facilitate the identification of PLWH who are out of care and not virally suppressed to offer them MAPS+. The set of implementation strategies include task-shifting the delivery of MAPS+ to CHWs, providing the CHWs training and ongoing support, and increasing communication between the CHWs and medical care team via standardized protocols. The investigators will conduct a hybrid type II effectiveness-implementation trial with a stepped-wedge cluster randomized design in 12 clinics to test MAPS+ compared to usual care using a set of implementation strategies that will best support implementation. Each clinic will be randomized to one of three implementation start times. Baseline (usual care) data will be collected from each clinic for 6 months, followed by MAPS+ and the package of implementation strategies for 12 months, in three cohorts of 4 clinics each. Aim 1 will test the effectiveness of MAPS+ on clinical effectiveness outcomes, including viral suppression (primary) and retention (secondary). Aim 2 will examine the effect of the package of implementation strategies on reach. Implementation cost will also be measured. Aim 3 will apply a qualitative approach to understand processes, mechanisms, and sustainment of the implementation approach. The results will guide future efforts to implement behavioral EBPs across the HIV care continuum, consistent with the "treat" pillar of EHE, and move the science of implementation services, consistent with NIH strategic priorities.

Status (registry)
Completed
Study type
Interventional
Enrollment
210 (actual)
First submitted
17 Sept 2020
Start date
1 Feb 2022
Primary completion date
30 Jun 2025
Lead sponsor
University of Pennsylvania
Diseases
HIV
NCT number
NCT04560621

What you commit to

  • Study type: Interventional
  • Participants enrolled: 210
  • From 1 Feb 2022 to the primary completion date, 30 Jun 2025
  • 10 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \- incarcerated during the duration of the trial

Who the study is looking for

  • age 18 or older
  • a man or woman living with HIV
  • not retained in care and/or virally suppressed in year prior to trial initiation

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (10)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cooper Early Intervention Program and Infectious Diseases
Coordinator of this site? Confirm its status
CamdenUnited StatesUnknown status
PHMC Care Clinic
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
Jefferson HIV Ambulatory Care Program
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
Einstein Immunodeficiency Center
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
Mazzoni Center
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
The Drexel Partnership Comprehensive Care Practice
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
MacGregor Infectious Diseases Clinic at the University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
Philadelphia FIGHT
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
Penn Presbyterian Medical Center Infectious Diseases Specialty Clinic at the University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status
Temple Comprehensive HIV Program
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.